|
DCP1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.616890E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.44049999999341E-05 |
| Normal-vs-Stage2 |
6.845400E-01 |
| Normal-vs-Stage3 |
1.138380E-01 |
| Normal-vs-Stage4 |
9.535500E-02 |
| Stage1-vs-Stage2 |
1.479820E-02 |
| Stage1-vs-Stage3 |
5.646500E-02 |
| Stage1-vs-Stage4 |
1.434560E-01 |
| Stage2-vs-Stage3 |
3.853800E-01 |
| Stage2-vs-Stage4 |
3.016000E-01 |
| Stage3-vs-Stage4 |
8.429800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.439780E-03 |
| Normal-vs-AfricanAmerican |
4.327000E-01 |
| Normal-vs-Asian |
6.393400E-04 |
| Caucasian-vs-AfricanAmerican |
3.489400E-01 |
| Caucasian-vs-Asian |
9.660400E-02 |
| AfricanAmerican-vs-Asian |
9.272500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.382060E-03 |
| Normal-vs-Female |
1.959720E-02 |
| Male-vs-Female |
4.563800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.328580E-01 |
| Normal-vs-Age(41-60Yrs) |
4.361500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.537590E-02 |
| Normal-vs-Age(81-100Yrs) |
5.822600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.995800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.632800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.206180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.285600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.517900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.214100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.205900E-02 |
| Normal-vs-Grade 2 |
1.032060E-04 |
| Normal-vs-Grade 3 |
5.392200E-02 |
| Normal-vs-Grade 4 |
2.218400E-01 |
| Grade 1-vs-Grade 2 |
1.549250E-01 |
| Grade 1-vs-Grade 3 |
4.184500E-02 |
| Grade 1-vs-Grade 4 |
2.572300E-02 |
| Grade 2-vs-Grade 3 |
4.041600E-02 |
| Grade 2-vs-Grade 4 |
5.650400E-02 |
| Grade 3-vs-Grade 4 |
7.314400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.437300E-04 |
| Normal-vs-ccB subtype |
1.707520E-02 |
| ccA subtype-vs-ccB subtype |
4.072000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.977900E-03 |
| Normal-vs-N1 |
2.129800E-01 |
| N0-vs-N1 |
8.618800E-01 |
|
|
